- 2/28: Endocyte prices 17,857,143 common stock offering at $4.20/share
WEST LAFAYETTE, Ind. (AP) _ Endocyte Inc. (ECYT) on Monday reported a loss of $8.6 million in its fourth quarter.
On a per-share basis, the West Lafayette, Indiana-based company said it had a loss of 18 cents.
The biopharmaceutical company posted revenue of $12,000 in the period.
For the year, the company reported that its loss widened to $55.1 million, or $1.25 per share. Revenue was nearly unchanged at $70,000.
The company's shares closed at $3.89. A year ago, they were trading at $2.04.